• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Jim Cramer Like MGM Growth Properties

    12/21/21 8:31:39 AM ET
    $AEVA
    $CMPS
    $DOMA
    $EPD
    Auto Parts:O.E.M.
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AEVA alert in real time by email

    On CNBC’s "Mad Money Lightning Round," Jim Cramer said Enterprise Products Partners L.P. (NYSE:EPD) is a "very good company." He noted that the stock is moving lower, in part, due to those owning these master limited partnerships selling the stock.

    "We are totally against companies that have no earnings," Cramer said when asked about Aeva Technologies, Inc. (NYSE:AEVA).

    Cramer indicated that he likes MGM Growth Properties LLC (NYSE:MGP) as the company has a very good cash flow with a 5.5% dividend yield. He recommended sticking with the stock.

    When asked about COMPASS Pathways plc (NASDAQ:CMPS), Cramer said, "If it doesn’t have earnings or the prospect of earnings very soon, I have to say no."

    He recommended staying away from Inovio Pharmaceuticals, Inc. (NASDAQ:INO).

    The "Mad Money" host also said no to blank check companies, also known as SPACs, when asked about TPG Pace Beneficial Finance Corp. (NYSE:TPGY). He expressed concern about the anticipated Fed policy changes.

    "The Fed has decided to go against the bulls, and I cannot just continue to dig in my heels with companies that I think are going to lose people money because at one point, before the Fed decided to tighten, I may have liked it," Cramer said. "I made a mistake, I have to move forward."

    When asked about Doma Holdings Inc. (NYSE:DOMA), the "Mad Money" host said, "Lump of coal, most definitely."

    Related Link: Jim Cramer Shares His Thoughts On Medtronic, Peloton Interactive And More

    Photo: Courtesy of Pixabay

    Get the next $AEVA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEVA
    $CMPS
    $DOMA
    $EPD

    CompanyDatePrice TargetRatingAnalyst
    Enterprise Products Partners L.P.
    $EPD
    2/4/2026$33.00 → $34.00Hold
    TD Cowen
    Enterprise Products Partners L.P.
    $EPD
    1/14/2026$31.00Peer Perform → Underperform
    Wolfe Research
    Enterprise Products Partners L.P.
    $EPD
    1/12/2026$33.00Hold
    Jefferies
    Enterprise Products Partners L.P.
    $EPD
    1/5/2026$36.00Strong Buy → Outperform
    Raymond James
    Enterprise Products Partners L.P.
    $EPD
    12/18/2025$34.00Equal-Weight → Underweight
    Morgan Stanley
    COMPASS Pathways Plc
    $CMPS
    12/10/2025$15.00Perform → Outperform
    Oppenheimer
    Enterprise Products Partners L.P.
    $EPD
    12/1/2025$35.00Overweight → Neutral
    Analyst
    Inovio Pharmaceuticals Inc.
    $INO
    7/9/2025$5.00Overweight
    Piper Sandler
    More analyst ratings

    $AEVA
    $CMPS
    $DOMA
    $EPD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Enterprise Reports Fourth Quarter 2025 Earnings

    Enterprise Products Partners L.P. ("Enterprise") (NYSE:EPD) today announced its financial results for the three months and year ended December 31, 2025. Year End 2025 Results Enterprise reported net income attributable to common unitholders of $5.8 billion, or $2.66 per common unit on a fully diluted basis, for 2025, compared to $5.9 billion, or $2.69 per common unit on a fully diluted basis, for 2024. Operational distributable cash flow ("Operational DCF") was $7.9 billion for 2025 and 2024. Distributions declared with respect to 2025 increased 3.6 percent to $2.175 per common unit, compared to distributions declared for 2024. 2025 marked Enterprise's 27th consecutive year of distrib

    2/3/26 6:00:00 AM ET
    $EPD
    Natural Gas Distribution
    Utilities

    Aeva to Participate in the Oppenheimer 11th Annual Emerging Growth Conference

    Aeva® (NASDAQ:AEVA), a leader in next-generation sensing and perception systems, today announced that Aeva management will participate in the following investor event: Oppenheimer 11th Annual Emerging Growth Conference Location: Virtual Date: February 3, 2026 Institutional investors can contact their sales representative at Oppenheimer to register and request a meeting. About Aeva Technologies, Inc. (NASDAQ:AEVA) Aeva's mission is to bring the next wave of perception to a broad range of applications from automated driving, manufacturing automation and smart infrastructure, to robotics and consumer devices. Aeva is accelerating autonomy with its groundbreaking perception platform tha

    1/28/26 7:00:00 AM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    Aeva Selected by Forterra to Power Next-Generation Autonomous Defense Vehicles with 4D LiDAR

    First Win in Defense Expands Aeva's Momentum as a Trusted LiDAR Supplier for Defense Autonomy Programs Aeva® (NASDAQ:AEVA), a leader in next-generation sensing and perception systems, today announced that it has been selected by Forterra, a pioneer in full-stack autonomous mission systems for defense and complex operational environments, to provide its 4D LiDAR sensors and perception technology for Forterra's autonomous vehicle system, AutoDrive. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120910245/en/Forterra selects Aeva's 4D LiDAR technology for its next-generation autonomous defense vehicles. Forterra's autonomous s

    1/20/26 7:00:00 AM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AEVA
    $CMPS
    $DOMA
    $EPD
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Inovio Pharmaceuticals Inc.

    SCHEDULE 13G/A - INOVIO PHARMACEUTICALS, INC. (0001055726) (Subject)

    1/30/26 2:20:56 PM ET
    $INO
    Medical/Dental Instruments
    Health Care

    SEC Form 424B5 filed by Inovio Pharmaceuticals Inc.

    424B5 - INOVIO PHARMACEUTICALS, INC. (0001055726) (Filer)

    1/27/26 4:16:47 PM ET
    $INO
    Medical/Dental Instruments
    Health Care

    Inovio Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders

    8-K - INOVIO PHARMACEUTICALS, INC. (0001055726) (Filer)

    1/27/26 4:12:49 PM ET
    $INO
    Medical/Dental Instruments
    Health Care

    $AEVA
    $CMPS
    $DOMA
    $EPD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $AEVA
    $CMPS
    $DOMA
    $EPD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $AEVA
    $CMPS
    $DOMA
    $EPD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Director Rutherford John R bought $481,334 worth of Common Units Representing Limited Partnership Interests (15,000 units at $32.09), increasing direct ownership by 9% to 173,586 units (SEC Form 4)

    4 - ENTERPRISE PRODUCTS PARTNERS L.P. (0001061219) (Issuer)

    12/29/25 4:06:04 PM ET
    $EPD
    Natural Gas Distribution
    Utilities

    Director Montgomery William C bought $504,864 worth of Common Units Representing Limited Partnership Interests (16,000 units at $31.55) (SEC Form 4)

    4 - ENTERPRISE PRODUCTS PARTNERS L.P. (0001061219) (Issuer)

    7/30/25 4:34:00 PM ET
    $EPD
    Natural Gas Distribution
    Utilities

    Director Rutherford John R bought $470,220 worth of Common Units Representing Limited Partnership Interests (15,000 units at $31.35), increasing direct ownership by 10% to 158,586 units (SEC Form 4)

    4 - ENTERPRISE PRODUCTS PARTNERS L.P. (0001061219) (Issuer)

    7/29/25 4:10:33 PM ET
    $EPD
    Natural Gas Distribution
    Utilities

    Chief Executive Officer Nath Kabir covered exercise/tax liability with 16,181 units of Ordinary Shares, decreasing direct ownership by 7% to 205,121 units (SEC Form 4)

    4 - COMPASS Pathways plc (0001816590) (Issuer)

    2/3/26 5:19:56 PM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Sinha Saurabh sold $1,238,578 worth of shares (60,000 units at $20.64), decreasing direct ownership by 9% to 627,756 units (SEC Form 4)

    4 - Aeva Technologies, Inc. (0001789029) (Issuer)

    1/15/26 9:00:04 PM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    Chief Executive Officer Dardashti Soroush Salehian sold $1,221,390 worth of shares (64,787 units at $18.85), gifted 164,000 shares and received a gift of 164,000 shares, decreasing direct ownership by 4% to 1,766,412 units (SEC Form 4)

    4 - Aeva Technologies, Inc. (0001789029) (Issuer)

    1/13/26 8:00:04 PM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    TD Cowen reiterated coverage on Enterprise Products with a new price target

    TD Cowen reiterated coverage of Enterprise Products with a rating of Hold and set a new price target of $34.00 from $33.00 previously

    2/4/26 7:04:01 AM ET
    $EPD
    Natural Gas Distribution
    Utilities

    Enterprise Products downgraded by Wolfe Research with a new price target

    Wolfe Research downgraded Enterprise Products from Peer Perform to Underperform and set a new price target of $31.00

    1/14/26 8:26:34 AM ET
    $EPD
    Natural Gas Distribution
    Utilities

    Jefferies initiated coverage on Enterprise Products with a new price target

    Jefferies initiated coverage of Enterprise Products with a rating of Hold and set a new price target of $33.00

    1/12/26 7:36:26 AM ET
    $EPD
    Natural Gas Distribution
    Utilities

    $AEVA
    $CMPS
    $DOMA
    $EPD
    Leadership Updates

    Live Leadership Updates

    View All

    Morning Market Pulse: AI, Autonomy, and National Security Drive the Narrative at the Open

    DENVER, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Markets are waking up to a distinctly forward-looking tape, with investors parsing developments that point to shifts in Artificial Intelligence infrastructure, advanced sensing, defense-aligned energy systems, and deep-tech R&D platforms. Envirotech Vehicles (NASDAQ:EVTV): Strategic Pivot Toward AI Infrastructure Envirotech Vehicles is in focus after announcing an amended and restated Letter of Intent to acquire AZIO AI Corporation, a move that could dramatically reshape the company's long-term identity. The proposed all-equity transaction values AZIO AI at an assumed enterprise value of $480 million, using a $3.00 per share reference price for E

    1/6/26 9:52:32 AM ET
    $AEVA
    $EVTV
    $OPTT
    Auto Parts:O.E.M.
    Consumer Discretionary
    Electric Utilities: Central
    Utilities

    Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

    LONDON and PHILADELPHIA, July 01, 2025 (GLOBE NEWSWIRE) -- Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announces the appointment of David Liebowitz, M.D., Ph.D. as Chief Medical Officer (CMO) and Yulii Bogatyrenko as an advisor in business development. Dr. Liebowitz will lead the Company's clinical strategy and execution as it continues to advance its pipeline of targeted cancer therapies and Mr. Bogatyrenko will add additional strength to the Group's business development strategy. Dr. Liebowitz is a seasoned hematologist-oncologist and drug development leader with more than 30 years of experience across academia and indust

    7/1/25 7:00:00 AM ET
    $INO
    Medical/Dental Instruments
    Health Care

    Aeva Announces First Strategic Customers for High-Precision Industrial Automation Sensors

    Leading Automation Companies Including SICK AG and LMI Technologies Place Initial Orders for Over 1,000 Eve 1 Sensors Aeva® (NASDAQ:AEVA), a leader in next-generation sensing and perception systems, today announced the first orders for its Aeva Eve™ 1 line of high-precision sensors for high-volume and inline industrial automation applications. Since recently announcing the product line, Aeva has received its first purchase orders for more than 1,000 sensors through collaborations with industry leaders including SICK AG and LMI Technologies. These early engagements reflect Aeva's successful expansion into the growing factory and process automation markets, beyond automotive 4D LiDAR technol

    5/12/25 7:00:00 AM ET
    $AEVA
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AEVA
    $CMPS
    $DOMA
    $EPD
    Financials

    Live finance-specific insights

    View All

    Enterprise Reports Fourth Quarter 2025 Earnings

    Enterprise Products Partners L.P. ("Enterprise") (NYSE:EPD) today announced its financial results for the three months and year ended December 31, 2025. Year End 2025 Results Enterprise reported net income attributable to common unitholders of $5.8 billion, or $2.66 per common unit on a fully diluted basis, for 2025, compared to $5.9 billion, or $2.69 per common unit on a fully diluted basis, for 2024. Operational distributable cash flow ("Operational DCF") was $7.9 billion for 2025 and 2024. Distributions declared with respect to 2025 increased 3.6 percent to $2.175 per common unit, compared to distributions declared for 2024. 2025 marked Enterprise's 27th consecutive year of distrib

    2/3/26 6:00:00 AM ET
    $EPD
    Natural Gas Distribution
    Utilities

    Enterprise Declares Quarterly Distribution

    Enterprise Products Partners L.P. (NYSE:EPD) ("Enterprise") announced today that the board of directors of its general partner declared a quarterly cash distribution to be paid to Enterprise common unitholders with respect to the fourth quarter of 2025 of $0.55 per unit, or $2.20 per unit on an annualized basis. The quarterly distribution will be paid Friday, February 13, 2026, to common unitholders of record as of the close of business Friday, January 30, 2026. This distribution represents a 2.8 percent increase over the distribution declared with respect to the fourth quarter of 2024. Enterprise repurchased approximately $50 million of its common units during the fourth quarter of 202

    1/8/26 11:07:00 AM ET
    $EPD
    Natural Gas Distribution
    Utilities

    INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

    Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review Expect to receive file acceptance by year end 2025 with potential PDUFA date in mid-2026 if request for priority review grantedCommercial preparations continuing for potential launch in mid-2026 if INO-3107 is approved by FDA Results from Phase 1 proof-of-concept trial evaluating INOVIO's next generation DNA-Encoded Monoclonal Antibody (DMAb™) technology published in Nature MedicinePLYMOUTH MEETING, Pa., Nov. 10, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help trea

    11/10/25 4:05:00 PM ET
    $INO
    Medical/Dental Instruments
    Health Care

    $AEVA
    $CMPS
    $DOMA
    $EPD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by COMPASS Pathways Plc

    SC 13G/A - COMPASS Pathways plc (0001816590) (Subject)

    11/14/24 4:35:16 PM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by COMPASS Pathways Plc

    SC 13G/A - COMPASS Pathways plc (0001816590) (Subject)

    11/14/24 4:20:24 PM ET
    $CMPS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Inovio Pharmaceuticals Inc.

    SC 13G - INOVIO PHARMACEUTICALS, INC. (0001055726) (Subject)

    4/26/24 4:01:17 PM ET
    $INO
    Medical/Dental Instruments
    Health Care